Research
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials
BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39548.738368.BE (Published 15 May 2008) Cite this as: BMJ 2008;336:1121
Data supplement
Web extras
Web extras
Files in this Data Supplement:
- Table A - Table A
- Web references - Web references
Related articles
- Editorial Published: 15 May 2008; BMJ 336 doi:10.1136/bmj.39560.541725.80
- Editor's Choice Published: 15 May 2008; BMJ 336 doi:10.1136/bmj.39581.553924.47
- Research Published: 19 May 2009; BMJ 338 doi:10.1136/bmj.b1665
- Analysis Published: 13 January 2012; BMJ 344 doi:10.1136/bmj.d8078
- Editorial Published: 31 January 2018; BMJ 360 doi:10.1136/bmj.k275
- Research Published: 18 November 2020; BMJ 371 doi:10.1136/bmj.m4080
See more
- Cardiac arrest occurs in three in 10 000 surgeries involving anaesthesia, audit findsBMJ November 20, 2023, 383 p2737; DOI: https://doi.org/10.1136/bmj.p2737
- Hypertension: 76 million deaths could be averted by 2050 if treatment coverage improves, says WHOBMJ September 20, 2023, 382 p2154; DOI: https://doi.org/10.1136/bmj.p2154
- Capacity problems in the NHS’s cardiac cath labs are harming patientsBMJ September 13, 2023, 382 p1953; DOI: https://doi.org/10.1136/bmj.p1953
- Threats to human health multiply amid record global temperaturesBMJ August 07, 2023, 382 p1819; DOI: https://doi.org/10.1136/bmj.p1819
- GP leaders advise practices not to prescribe cholesterol lowering drug inclisiranBMJ August 01, 2023, 382 p1757; DOI: https://doi.org/10.1136/bmj.p1757
Cited by...
- Effect of antihypertensive drug treatment on long-term blood pressure reduction: An individual patient-level data meta-analysis of 352,744 Participants from 51 large-scale randomised clinical trials
- First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care
- L-type Ca2+ channel blockers promote vascular remodeling through activation of STIM proteins
- Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974-2015?
- Association of the low e' and high E/e' with long-term outcomes in patients with normal ejection fraction: a hospital population-based observational cohort study
- Blood pressure management in the elderly: the need for more randomised evidence
- How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure
- Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC)
- Association between gaps in antihypertensive medication adherence and injurious falls in older community-dwelling adults: a prospective cohort study
- Investigation and management of adult hypertension
- Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)
- Cost-effectiveness of interventions to control cardiovascular diseases and diabetes mellitus in South Asia: a systematic review
- Stroke Prevention in the Very Elderly
- Racial/ethnic heterogeneity in associations of blood pressure and incident cardiovascular disease by functional status in a prospective cohort: the Multi-Ethnic Study of Atherosclerosis
- Migraine and risk of cardiovascular disease
- Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment--Results from the Randomized TEAMSTA Protect I Trial
- Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America
- Systolic Blood Pressure and Vascular Disease in Men Aged 65 Years and Over: The HIMS (Health in Men Study)
- Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study
- China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients
- Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs
- Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease
- Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
- Resourcing Drug Development Commensurate With its Public Health Importance: The Road Ahead
- What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?
- Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment
- Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization Among Patients With Newly Prescribed Antihypertensive Medications
- Garlic and Heart Disease
- Cardiovascular Drug Development: Is it Dead or Just Hibernating?
- Age-Related Difference in the Sleep Pressure-Lowering Effect Between an Angiotensin II Receptor Blocker and a Calcium Channel Blocker in Asian Hypertensives: The ACS1 Study
- Predicting the Effects of Blood Pressure-Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus: Results From Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation
- Physical Activity and Exercise After Stroke: Review of Multiple Meaningful Benefits
- Obstructive sleep apnoea and hypertension: the ESADA study
- Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population
- An evolving story of angiotensin-II-forming pathways in rodents and humans
- Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
- Blood Pressure Management in the 21st Century: Maximizing Gains and Minimizing Waste
- Influence of retirement on nonadherence to medication for hypertension and diabetes
- Individualization of Antihypertensive Drug Treatment
- Targets for Body Fat, Blood Pressure, Lipids, and Glucose-Lowering Interventions in Healthy Older People
- Blood Pressure in Treated Hypertensive Individuals With the MTHFR 677TT Genotype Is Responsive to Intervention With Riboflavin: Findings of a Targeted Randomized Trial
- ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
- Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region
- Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
- The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
- Salt sensitivity of blood pressure: developmental and sex-related effects
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension
- Efficacy and Duration of Benazepril Plus Amlodipine or Hydrochlorthiazide on 24-Hour Ambulatory Systolic Blood Pressure Control
- "The Lower the BP the Better" Paradigm in the Elderly: Vanished by VALISH?
- The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
- Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study
- Geriatric Nephrology: Responding to a Growing Challenge
- Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
- Angiotensin Receptor Blockers and Stroke Therapy: It Is All About the Blood Pressure
- Large and Small Artery Cross-Talk and Recent Morbidity-Mortality Trials in Hypertension
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
- A Virtuous Cycle to Improve Hypertension Outcomes at a National Level: Linking Public Health and Individualized Medicine
- Resistant Hypertension: An Overview of Evaluation and Treatment
- Blood pressure guidelines - where are we now?
- No Need to Select Specific Antihypertensive Drugs According to Age
- Reducing blood pressure in people of different ages